Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 Interest Coverage is 5.18 as of Dec. 2025, which is 72% below its 10-year median of 18.65. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 376 Biotechnology companies, Synbio Tech ranks worse than 71.01% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Synbio Tech's
Operating Income
for the
three
months ended in Dec. 2025 was NT$33 Mil. Synbio Tech's Interest Expense for the
three
months ended in Dec. 2025 was NT$-6 Mil.
Synbio Tech's interest coverage for the quarter that ended in Dec. 2025 was 5.18.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Synbio Tech's Interest Coverage or its related term are showing as below:
ROCO:1295'
s Interest Coverage Range Over the Past 10 Years
Min: 13.24 Med: 18.65 Max: 56.43
Current: 15.62
ROCO:1295's Interest Coverage is ranked worse than 71.01% of 376
companies
in the Biotechnology industry
Industry Median: 104.025
vs ROCO:1295: 15.62
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Synbio Tech Interest Coverage Related Terms
Synbio Tech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:1295 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Synbio Tech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a Interest Coverage of 5.18 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Synbio Tech and its competitors. This is 72% below median its historical median of 18.65. Over the past decade, Synbio Tech's Interest Coverage has ranged from 13.24 to 56.43. According to the industry distribution chart, Synbio Tech ranks #267 out of 376 companies in the Biotechnology industry, placing it in the top 71%.
Is Synbio Tech's Interest Coverage too high?
Synbio Tech's current Interest Coverage of 5.18 is 72% below median its 10-year median of 18.65. Over the past 10 years, this metric has ranged from a low of 13.24 to a high of 56.43. The Biotechnology industry median Interest Coverage is 104.03. Synbio Tech's value of 5.18 is 95% below this industry median. Based on the distribution chart, Synbio Tech ranks #267 out of 376 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #267 out of 376 companies for Interest Coverage. This places Synbio Tech in the lower half of its industry. The industry median Interest Coverage is 104.03. Synbio Tech's value of 5.18 is 95% below this benchmark. Historically, Synbio Tech's own Interest Coverage has ranged from 13.24 to 56.43 over the past decade. While the company's 10-year median is 18.65 vs. the industry median of 104.03, Synbio Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.03, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current Interest Coverage of 5.18 is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current Interest Coverage is 5.18, which is 72% below median its own 10-year median of 18.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Interest Coverage of 5.18. The current Interest Coverage is 5.18, which is 72% below median its 10-year median of 18.65 and 95% below the Biotechnology industry median of 104.03. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Interest Coverage is 5.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
